A Phase II Study of CCI-779 in Metastatic Neuroendocrine Carcinomas.
Phase of Trial: Phase II
Latest Information Update: 09 Feb 2017
At a glance
- Drugs Temsirolimus (Primary)
- Indications Neuroendocrine carcinoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 14 Jun 2012 Trial locations (USA and Canada) added as reported by ClinicalTrials.gov.
- 14 Jun 2012 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.